Healthcare | March 25, 2025
Our TB elimination strategy is based on ‘whole of the society’ and ‘whole of the government’ approach: JP Nadda
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Experts urge early detection & better access to care
Overall investment in the US facility is estimated around US$50 million
This addition strengthens Dr. Agarwals Eye Hospital's vast network of 28 hospitals across Karnataka and 220+ facilities worldwide
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Findings to form the basis for a Phase 3 program, anticipated to start in H2 2025
Subscribe To Our Newsletter & Stay Updated
